Skip to main content

Find Clinical Trials

Home
Conditions
Immunologic Deficiency Syndromes

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,128 public trials 394 recruiting studies

Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs

NCT00183456

Conditions: Blood-Borne Infections, Communicable Diseases, Disease Attributes, +14 more
Locations: The Lighthouse Baltimore, Maryland, United States

View Trial Details

Completed

Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.

NCT00158821

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency

NCT00520494

Conditions: Agammaglobulinemia, Blood Protein Disorders, Bruton type agammaglobulinemia, +10 more
Locations: Contact CSL Behring for facility details Edmonton, Alberta, Canada

Contact CSL Behring for facility details Montreal, Quebec, Canada

Contact CSL Behring for facility details Leipzig, Germany

Contact CSL Behring for facility details Brescia, Italy

View Trial Details

Completed

A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study

NCT00128830

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens

NCT00152061

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Santa Clara Medical Center, PACE Clinic San Jose, California, United States

View Trial Details

Completed

Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency

NCT00680446

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations: Campbelltown Hospital Campbelltown, New South Wales, Australia

Sydney Children's Hospital Randwick, New South Wales, Australia

Royal Adelaide Hospital Adelaide, South Australia, Australia

Women's & Children's Hospital North Adelaide, South Australia, Australia

View Trial Details

Completed

Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)

NCT00951028

Conditions: Behavior, Behavioral Symptoms, Blood-Borne Infections, +15 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Fenway Community Health Center Boston, Massachusetts, United States

Butler Hospital Providence, Rhode Island, United States

The Miriam Hospital Providence, Rhode Island, United States

View Trial Details

Completed

Adherence Intervention for People With Low-literacy

NCT01061762

Conditions: Behavior, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Southeast HIV/AIDS Research and Evaluation Project Atlanta, Georgia, United States

View Trial Details

Completed

A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients

NCT00838162

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Berlin, Germany

Frankfurt, Germany

Hamburg, Germany

View Trial Details

Completed

Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS

NCT00963235

Conditions: Acquired Immunodeficiency Syndrome, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations: Pfizer Investigational Site San Francisco, California, United States

Pfizer Investigational Site Aurora, Colorado, United States

Pfizer Investigational Site Washington D.C., District of Columbia, United States

Pfizer Investigational Site Lexington, Kentucky, United States

View all 15 locations

View Trial Details